70 likes | 332 Vues
Treatment of Chronic HCV Genotype 2 thru 6 . Treatment duration 24 weeks Ribavirin fixed dose – 800 mg/daily Currently HCV protease inhibitors are not approved to treat genotype 2 and 3 . Treatment: Genotype 2 and 3 Pegylated and Ribavirin (FDA Package Insert) .
E N D
Treatment of Chronic HCV Genotype 2 thru 6 • Treatment duration 24 weeks • Ribavirin fixed dose – 800 mg/daily • Currently HCV protease inhibitors are not approved to treat genotype 2 and 3
Treatment: Genotype 2 and 3Pegylated and Ribavirin (FDA Package Insert) • Merck /Schering – PEG-Intron + Rebetol (800-1400mg) • Genotype 2 thru 6 – 75% (48 weeks) • One large multi-international study • Genentech/Roche – Pegasys + Copegus (1000-1200 mg) • Genotype 2 & 3 – 82% SVR (24 weeks) • Genotype 2 thru 6 – 70% SVR (48 weeks) • Two large multi-international studies * Also approved to treat compensated cirrhosis, HIV/HCV Coinfection, Renal (mono) and HBV (mono)
Treatment of HCV Genotype 1 • Only approved for chronic HCV genotype 1 • Treatment with an HCV protease inhibitor is only used in combination with pegylated interferon and ribavirin • The HCV protease inhibitors are taken every 7 to 9 hours with food: • Boceprevir – light meal / Telaprevir –not low fat
Victrelis (Boceprevir)4-week lead in – Peg/Rbv treatment naïve – Genotype 1 Up to 66% SVR African Americans – up to 53% vs. 23% SVR Treatment duration either 28 or 48 weeks Treatment Experienced – Genotype 1 Prior non-responders–up to 66% SVR (null responders not studied) Treatment duration 36 or 48 weeks www.hcvadvocate.org
Incivek (Telaprevir)Incivek, pegylated interferon, ribavirin taken for 12 weeks only—followed by pegylated interferon/ribavirin Treatment naïve – Genotype 1: Up to 79% SVR African American patients: 62% vs. 25% SVR People with cirrhosis: 62% vs. 33% SVR Treatment Experienced – genotype 1: Up to 86% SVR depending on type of non-response (relapsers, non-responders, null responders) *Treatment duration 24 or 48 weeks www.hcvadvocate.org
Standard Protocol • Pegylated (injected once a week) • Ribavirin (pill or capsule – oral twice a day) with food • Victrelis / Incivek (pill—every 7 to 9 hours) for genotype 1 only with food • Treatment is guided by type of on-treatment response (week 4 and 12)